Vivek Ramaswamy, a prominent biotech entrepreneur and former Republican presidential candidate, has recently gained attention following his appointment to lead the Department of Government Efficiency (DOGE) alongside Elon Musk in President Donald Trump's administration. With a substantial fortune built through Roivant Sciences and Strive Asset Management, Ramaswamy is known for his conservative views and business acumen. His role in DOGE represents a milestone in his political career, aligning with efforts to reform federal bureaucracy.
Costco has recalled nearly 80,000 pounds of Kirkland Signature butter due to a critical labeling omission of the 'Contains Milk' allergen statement. The FDA has classified this recall as 'Class II,' suggesting that while the risk of serious health issues is low, consumers, especially those with milk allergies, should return the products for a refund. The humorous reaction on social media highlights the importance of accurate allergen labeling in food products.
On November 13, 2024, Krispy Kreme will celebrate World Kindness Day by giving away a free dozen Original Glazed doughnuts to the first 500 customers at participating locations across the U.S. The promotion aims to inspire kindness and small acts of generosity. Dave Skena, Krispy Kreme's Global Chief Brand Officer, highlights the importance of small gestures. Additionally, a Thanksgiving collection of holiday pie-inspired flavors has been launched.
Polymarket has indicated an 88% chance that Scott Bessent, a hedge fund manager and prominent fundraiser for Donald Trump, will be appointed Treasury Secretary if Trump secures a second term. Bessent, known for advocating cryptocurrency, particularly Bitcoin, could reshape U.S. economic policy regarding digital assets. His proactive approach and connections within the Republican Party suggest a significant shift towards pro-crypto regulatory environments in a potential Trump administration.
Pharmaceutical giant GSK is experiencing significant developments including its exit from the Biotechnology Innovation Organization and a $2.2 billion settlement over Zantac lawsuits. Despite the tumult, GSK's share value increased by 6% following the settlement, while the company announced a quarterly dividend of 15 pence amidst broader concerns over its financial strategies and the future of dividend payments.